XML 22 R10.htm IDEA: XBRL DOCUMENT v3.23.1
INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES
 12 Months Ended
Dec. 31, 2022
INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES  
NOTE 4 - INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES

NOTE 4 - INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES

 

The Company’s investments in marketable equity securities are being held for an indefinite period and thus have been classified as available for sale. Cost basis of securities held as of both December 31, 2022 and 2021 was $42,720, and accumulated unrealized losses were $42,720 as of December 31, 2022 and 2021, respectively. The fair market value of available for sale marketable securities was $0 as of December 31, 2022 and 2021, based on 178,000 shares of common stock held in one entity with a per share market price of approximately $0.00.

 

Net losses on equity investments were as follows:

 

 

 

Years Ended

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Net realized losses on investment sold or assigned

 

$-

 

 

$

-

 

Net unrealized losses on investments still held

 

 

-

 

 

 

(1,424 )

 

 

 

 

 

 

 

 

 

Total

 

$-

 

 

$(1,424 )

 

The reconciliation of the investment in marketable securities is as follows for the years ended December 31, 2022 and 2021:

 

 

 

December 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Beginning Balance - December 31

 

$-

 

 

$1,424

 

Additions

 

 

-

 

 

 

-

 

Proceeds on sales of securities

 

 

-

 

 

 

-

 

Assignment of securities as compensation

 

 

-

 

 

 

-

 

Recognized losses

 

 

-

 

 

 

(1,424 )

Ending Balance - December 31

 

$-

 

 

$-